Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11870)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2014 (publication date) through Dec 7, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Heebøll S, Thomsen KL, Pedersen SB, Vilstrup H, George J, Grønbæk H. Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease. World J Hepatol 2014; 6(4): 188-198 [PMID: 24799987 DOI: 10.4254/wjh.v6.i4.188] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i4/188.htm |
| Number | Citing Articles |
| 1 |
Weigang Yuan, Mi Zhang, Chunxu Wang, Bin Li, Lei Li, Feng Ye, Chuanrui Xu. Resveratrol Attenuates High-Fat Diet–Induced Hepatic Lipotoxicity by Upregulating Bmi-1 Expression. Journal of Pharmacology and Experimental Therapeutics 2022; 381(2): 96 doi: 10.1124/jpet.121.001018
|
| 2 |
Jung-Hwan Kang, Se-Young Choung. Protective effects of resveratrol and its analogs on age-related macular degeneration in vitro. Archives of Pharmacal Research 2016; 39(12): 1703 doi: 10.1007/s12272-016-0839-0
|
| 3 |
Marina Vilaseca, Jordi Gracia-Sancho. Portal Hypertension VII. 2022; : 201 doi: 10.1007/978-3-031-08552-9_18
|
| 4 |
Fu-Chao Liu, Yung-Fong Tsai, Hsin-I Tsai, Huang-Ping Yu, Zhengyuan Xia. Anti‐Inflammatory and Organ‐Protective Effects of Resveratrol in Trauma‐Hemorrhagic Injury. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/643763
|
| 5 |
Haoyue Deng, Man-tian Mi. Resveratrol Attenuates Aβ25–35 Caused Neurotoxicity by Inducing Autophagy Through the TyrRS-PARP1-SIRT1 Signaling Pathway. Neurochemical Research 2016; 41(9): 2367 doi: 10.1007/s11064-016-1950-9
|
| 6 |
Jenifer Trepiana, Iñaki Milton-Laskibar, Saioa Gómez-Zorita, Itziar Eseberri, Marcela González, Alfredo Fernández-Quintela, María P. Portillo. Involvement of 5′AMP-Activated Protein Kinase (AMPK) in the Effects of Resveratrol on Liver Steatosis. International Journal of Molecular Sciences 2018; 19(11): 3473 doi: 10.3390/ijms19113473
|
| 7 |
Ali Bayoumi, Henning Grønbæk, Jacob George, Mohammed Eslam. The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease. Trends in Genetics 2020; 36(6): 429 doi: 10.1016/j.tig.2020.03.003
|
| 8 |
Eva Dolezelova, Alena Prasnicka, Jolana Cermanova, Alejandro Carazo, Lucie Hyrsova, Milos Hroch, Jaroslav Mokry, Michaela Adamcova, Alena Mrkvicova, Petr Pavek, Stanislav Micuda. Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats. World Journal of Gastroenterology 2017; 23(43): 7678-7692 doi: 10.3748/wjg.v23.i43.7678
|
| 9 |
Chan Yoon Park, Sung Nim Han. The Molecular Nutrition of Fats. 2019; : 103 doi: 10.1016/B978-0-12-811297-7.00008-1
|
| 10 |
HUI ZHANG, QINGFENG SUN, TINGYAN XU, LIANG HONG, RONGQUAN FU, JINGUO WU, JIGUANG DING. Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-κB pathways. Molecular Medicine Reports 2016; 13(1): 224 doi: 10.3892/mmr.2015.4497
|
| 11 |
Arefe Nemati, Zeinab Nikniaz, Ali Mota. Effects of Resveratrol Supplementation on Nonalcoholic Fatty Liver Disease Management. Topics in Clinical Nutrition 2023; 38(2): 144 doi: 10.1097/TIN.0000000000000314
|
| 12 |
Yong Zhang, Ming‐liang Chen, Yong Zhou, Long Yi, Yan‐xiang Gao, Li Ran, Shi‐hui Chen, Ting Zhang, Xi Zhou, Dan Zou, Bin Wu, Ying Wu, Hui Chang, Jun‐dong Zhu, Qian‐yong Zhang, Man‐tian Mi. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway. Molecular Nutrition & Food Research 2015; 59(8): 1443 doi: 10.1002/mnfr.201500016
|
| 13 |
Laura K. Cole, Edgard M. Mejia, Genevieve C. Sparagna, Marilyne Vandel, Bo Xiang, Xianlin Han, Nikolaos Dedousis, Brett A. Kaufman, Vernon W. Dolinsky, Grant M. Hatch. Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy. Journal of Molecular and Cellular Cardiology 2020; 144: 24 doi: 10.1016/j.yjmcc.2020.05.001
|
| 14 |
Sara Heebøll, Rime Bahij El‐Houri, Ylva Erika Kristina Hellberg, David Haldrup, Steen Bønløkke Pedersen, Niels Jessen, Lars Porskjær Christensen, Henning Grønbæk. Effect of resveratrol on experimental non‐alcoholic fatty liver disease depends on severity of pathology and timing of treatment. Journal of Gastroenterology and Hepatology 2016; 31(3): 668 doi: 10.1111/jgh.13151
|
| 15 |
Ji‐Won Kim, Ye‐Jee Lee, Young‐Hye You, Min Kyong Moon, Kun‐Ho Yoon, Yu‐Bae Ahn, Seung‐Hyun Ko. Effect of sodium‐glucose cotransporter 2 inhibitor, empagliflozin, and α‐glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetes. Journal of Cellular Biochemistry 2019; 120(5): 8534 doi: 10.1002/jcb.28141
|
| 16 |
Anne Korsholm, Thomas Kjær, Marie Ornstrup, Steen Pedersen. Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment. International Journal of Molecular Sciences 2017; 18(3): 554 doi: 10.3390/ijms18030554
|
| 17 |
Mitchell R. McGill, Kuo Du, James L. Weemhoff, Hartmut Jaeschke. Critical review of resveratrol in xenobiotic-induced hepatotoxicity. Food and Chemical Toxicology 2015; 86: 309 doi: 10.1016/j.fct.2015.11.003
|
| 18 |
Markus M. Heimesaat, Soraya Mousavi, Ulrike Escher, Fábia Daniela Lobo de Sá, Elisa Peh, Jörg-Dieter Schulzke, Sophie Kittler, Roland Bücker, Stefan Bereswill. Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention Study. Microorganisms 2020; 8(12): 1858 doi: 10.3390/microorganisms8121858
|
| 19 |
Mari Anoushka Ricker, William Christian Haas. Anti‐Inflammatory Diet in Clinical Practice: A Review. Nutrition in Clinical Practice 2017; 32(3): 318 doi: 10.1177/0884533617700353
|
| 20 |
Somayyeh Asghari, Mohammad Asghari-Jafarabadi, Mohammad-Hossein Somi, Seyed-Mostafa Ghavami, Maryam Rafraf. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. Journal of the American College of Nutrition 2018; 37(3): 223 doi: 10.1080/07315724.2017.1392264
|
| 21 |
Maria-Christina Scherzberg, Andreas Kiehl, Aleksandra Zivkovic, Holger Stark, Jürgen Stein, Robert Fürst, Dieter Steinhilber, Sandra Ulrich-Rückert. Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action. Toxicology and Applied Pharmacology 2015; 287(1): 67 doi: 10.1016/j.taap.2015.05.020
|
| 22 |
|
| 23 |
Jelica Grujic-Milanovic, Zoran Miloradovic, Djurdjica Jovovic, Vesna Jacevic, Ivica Milosavljevic, Sladjan D. Milanovic, Nevena Mihailovic-Stanojevic. The red wine polyphenol, resveratrol improves hemodynamics, oxidative defence and aortal structure in essential and malignant hypertension. Journal of Functional Foods 2017; 34: 266 doi: 10.1016/j.jff.2017.04.035
|
| 24 |
Sara Heebøll, Karen Louise Thomsen, Andrew Clouston, Elias Immanuel Sundelin, Yulia Radko, Lars Porskjær Christensen, Mehdi Ramezani-Moghadam, Martin Kreutzfeldt, Steen Bønløkke Pedersen, Niels Jessen, Lionel Hebbard, Jacob George, Henning Grønbæk. Effect of resveratrol on experimental non-alcoholic steatohepatitis. Pharmacological Research 2015; : 34 doi: 10.1016/j.phrs.2015.03.005
|
| 25 |
Alexander Wolf, Tobias Fink, Jochen Hinkelbein, Thilo Mertke, Thomas Volk, Alexander Mathes, Gianfranco D. Alpini. Resveratrol therapy improves liver function via estrogen-receptors after hemorrhagic shock in rats. PLOS ONE 2022; 17(10): e0275632 doi: 10.1371/journal.pone.0275632
|
| 26 |
Chih-Chun Chang, Chieh-Yu Chang, Pei-Chun Lin, Jiung-Pang Huang, Kuan-Hsing Chen, Tzung-Hai Yen, Li-Man Hung. Administration of Low-dose Resveratrol Attenuated Hepatic Inflammation and Lipid Accumulation in High Cholesterol-fructose Diet-induced Rat Model of Nonalcoholic Fatty Liver Disease. Chinese Journal of Physiology 2020; 63(4): 149 doi: 10.4103/CJP.CJP_43_20
|
| 27 |
Alexander N. Belyaev, Evgeny V. Boyarkin, Sergey V. Kostin, Pavel N. Parkin, Denis V. Babas, Sergey A. Belyaev. Free-radical liver damage correction in mechanical jaundice. Experimental and Clinical Gastroenterology 2022; (7): 165 doi: 10.31146/1682-8658-ecg-203-7-165-170
|
| 28 |
Havva Afshari, Shokoofe Noori, Afshin Zarghi. A novel combination of metformin and resveratrol alleviates hepatic steatosis by activating autophagy through the cAMP/AMPK/SIRT1 signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2023; 396(11): 3135 doi: 10.1007/s00210-023-02520-7
|
| 29 |
Julia Christenson, Serena J. Whitby, Duane Mellor, Jackson Thomas, Andrew McKune, Paul D. Roach, Nenad Naumovski. The Effects of Resveratrol Supplementation in Overweight and Obese Humans: A Systematic Review of Randomized Trials. Metabolic Syndrome and Related Disorders 2016; 14(7): 323 doi: 10.1089/met.2016.0035
|
| 30 |
Cong Liu, Jia-Zhi Liao, Pei-Yuan Li. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(11): 1964-1973 doi: 10.3748/wjg.v23.i11.1964
|
| 31 |
Miao Li, Yu Cai, Xi Chen, Luyong Zhang, Zhenzhou Jiang, Qinwei Yu. Tamoxifen induced hepatic steatosis in high-fat feeding rats through SIRT1-Foxo1 suppression and LXR-SREBP1c activation. Toxicology Research 2022; 11(4): 673 doi: 10.1093/toxres/tfac043
|
| 32 |
Marlies de Ligt, Silvie Timmers, Patrick Schrauwen. Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015; 1852(6): 1137 doi: 10.1016/j.bbadis.2014.11.012
|
| 33 |
|
| 34 |
Hina Rashid, Abdulmajeed Jali, Mohammad Suhail Akhter, Sayed Aliul Hasan Abdi. Molecular Mechanisms of Oxidative Stress in Acute Kidney Injury: Targeting the Loci by Resveratrol. International Journal of Molecular Sciences 2023; 25(1): 3 doi: 10.3390/ijms25010003
|
| 35 |
Antje Bruckbauer, Jheelam Banerjee, Lizhi Fu, Fenfen Li, Qiang Cao, Xin Cui, Rui Wu, Hang Shi, Bingzhong Xue, Michael B. Zemel. A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice. International Journal of Hepatology 2016; 2016: 1 doi: 10.1155/2016/9185987
|
| 36 |
Akhand Pratap Singh, Rachna Singh, Sumit Singh Verma, Vipin Rai, Catherine H. Kaschula, Pralay Maiti, Subash Chandra Gupta. Health benefits of resveratrol: Evidence from clinical studies. Medicinal Research Reviews 2019; 39(5): 1851 doi: 10.1002/med.21565
|
| 37 |
Manuela Pennisi, Gaetano Bertino, Caterina Gagliano, Michele Malaguarnera, Rita Bella, Antonio Borzì, Roberto Madeddu, Filippo Drago, Giulia Malaguarnera. Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance. Nutrients 2017; 9(8): 897 doi: 10.3390/nu9080897
|
| 38 |
Tomasz Charytoniuk, Ewa Harasim-Symbor, Agnieszka Polak, Krzysztof Drygalski, Klaudia Berk, Adrian Chabowski, Karolina Konstantynowicz-Nowicka. Influence of Resveratrol on Sphingolipid Metabolism in Hepatocellular Carcinoma Cells in Lipid Overload State. Anti-Cancer Agents in Medicinal Chemistry 2019; 19(1): 121 doi: 10.2174/1871520619666181224161255
|
| 39 |
Mojtaba Rashidi, Reza Afarin, Maryam Kouchak, Benyamin Kabizadeh, Masoumeh Shamsi, Mahdi Hatami. Resveratrol and Saroglitazar: A Promising Combination for Targeting TGF-β/Smad3 Signaling and Attenuating Inflammatory Response in Nonalcoholic Steatohepatitis in Rats. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-138237
|
| 40 |
Jia Liu, Yuan Xu, Yanjin Hu, Guang Wang. The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. Metabolism 2015; 64(3): 380 doi: 10.1016/j.metabol.2014.11.009
|
| 41 |
Kang Cheng, Zhihua Song, Hao Zhang, Simian Li, Chao Wang, Lili Zhang, Tian Wang. The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression. Medical Molecular Morphology 2019; 52(4): 187 doi: 10.1007/s00795-019-00216-7
|
| 42 |
Jenifer Trepiana, Stéphanie Krisa, Elodie Renouf, María Puy Portillo. Resveratrol Metabolites Are Able to Reduce Steatosis in Cultured Hepatocytes. Pharmaceuticals 2020; 13(10): 285 doi: 10.3390/ph13100285
|
| 43 |
Sahar Yarahmadi, Navid Farahmandian, Reza Fadaei, Mehdi Koushki, Elham Bahreini, Saeed Karima, Sepideh Barzin Tond, Azadeh Rezaei, Mitra Nourbakhsh, Soudabeh Fallah. Therapeutic Potential of Resveratrol and Atorvastatin Following High-Fat Diet Uptake-Induced Nonalcoholic Fatty Liver Disease by Targeting Genes Involved in Cholesterol Metabolism and miR33. DNA and Cell Biology 2023; 42(2): 82 doi: 10.1089/dna.2022.0581
|
| 44 |
Jean-Baptiste Moretti, Amélia Drouin, Caroline Truong, Elizabeth Youn, Anik Cloutier, Fernando Alvarez, Massimiliano Paganelli, Kelly Grzywacz, Prevost Jantchou, Josee Dubois, Emile Levy, Ramy El Jalbout. Effects of polyphenol supplementation on hepatic steatosis, intima-media thickness and non-invasive vascular elastography in obese adolescents: a pilot study protocol. BMJ Open 2024; 14(1): e074882 doi: 10.1136/bmjopen-2023-074882
|
| 45 |
Sara Heebøll, Martin Kreuzfeldt, Stephen Hamilton-Dutoit, Marianne Kjær Poulsen, Hans Stødkilde-Jørgensen, Holger Jon Møller, Niels Jessen, Kasper Thorsen, Ylva Kristina Hellberg, Steen Bønløkke Pedersen, Henning Grønbæk. Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2016; 51(4): 456 doi: 10.3109/00365521.2015.1107620
|
| 46 |
Tannaz Eslamparast, Sareh Eghtesad, Hossein Poustchi, Azita Hekmatdoost. Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. World Journal of Hepatology 2015; 7(2): 204-212 doi: 10.4254/wjh.v7.i2.204
|
| 47 |
Qing-Rong Pan, Yan-Long Ren, Wen-Xian Liu, Yan-Jin Hu, Jin-Su Zheng, Yuan Xu, Guang Wang. Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats. Nutrition Research 2015; 35(7): 576 doi: 10.1016/j.nutres.2015.05.006
|
| 48 |
Rehab M. Badi, Dalia G. Mostafa, Eman F. Khaleel, Huda H. Satti. Resveratrol protects against hepatic insulin resistance in a rat's model of non‐alcoholic fatty liver disease by down‐regulation of GPAT‐1 and DGAT2 expression and inhibition of PKC membranous translocation. Clinical and Experimental Pharmacology and Physiology 2019; 46(6): 545 doi: 10.1111/1440-1681.13074
|
| 49 |
Eman F. Khaleel, Ghada A. Abdel-Aleem, Dalia G. Mostafa. Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption. Canadian Journal of Physiology and Pharmacology 2018; 96(2): 145 doi: 10.1139/cjpp-2017-0001
|
| 50 |
Hüseyin ÖZDEN, Muhammed GÖMEÇ, Yaşar ŞAHİN, Gökhan KARACA, Huri BULUT, Asuman KİLİTCİ. Protective effect of resveratrol on the kidney in rats under immunosuppression with tacrolimus. Journal of Surgery and Medicine 2021; 5(2): 144 doi: 10.28982/josam.831592
|